Literature DB >> 8674175

Influence of HLA matching on thoracic transplant outcomes. An analysis from the UNOS/ISHLT Thoracic Registry.

J D Hosenpud1, E B Edwards, H M Lin, O P Daily.   

Abstract

BACKGROUND: The benefit of matching donor organs and recipients for HLAs has been well established in renal transplantation and has been suggested for thoracic organ transplantation. To determine the effect of HLA matching in cardiac and single-lung transplantation, the following study was performed. METHODS AND
RESULTS: Using the joint Thoracic Transplant Registry or the United Network for Organ Sharing and the International Society for Heart and Lung Transplantation, all adult primary heart and single-lung transplant procedures performed in the United States from October 1987 through December 1993 were analyzed to determine the effects of HLA matching on transplant mortality. Both total HLA matches and matches at individual HLA loci were considered. Including HLA matching, 16 potential risk factors for heart transplant outcome and 16 potential risk factors for lung transplant outcome were subjected to multivariate analysis. A total of 10752 heart transplants and 1239 lung transplants were included in the independent analyses for each organ. For heart transplantation, there was a progressive reduction in risk for greater matching (1 or 2 matches: risk ratio, 0.83; 3 matches: risk ratio, 0.67; 4 to 6 matches: risk ratio, 0.59; all P < or = .01). The primary benefit of matching appeared to be at the A and DR loci (risk ratios, 0.87 and 0.79, respectively; P < .001). For lung transplantation, any matching had an independent positive effect on outcome; however, the relationship between numbers of HLA matches and relative risk was not present and ranged from risk ratios of 0.71 to 0.87 (P = .01 and P = .47, respectively). In this analysis, only matching at the A locus appeared to statistically influence outcome (risk ratio, 0.76; P = .01).
CONCLUSIONS: These data demonstrate that HLA matching independently impacts survival in both heart and single-lung transplantation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8674175     DOI: 10.1161/01.cir.94.2.170

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

Review 1.  Mechanisms of chronic rejection in cardiothoracic transplantation.

Authors:  Matthew J Weiss; Joren C Madsen; Bruce R Rosengard; James S Allan
Journal:  Front Biosci       Date:  2008-01-01

2.  The influence of human leukocyte antigen matching on outcomes in pediatric heart transplantation.

Authors:  Salil Ginde; Thomas M Ellis; Melodee Nugent; Pippa Simpson; Gail Stendahl; Stuart Berger; Steven Zangwill
Journal:  Pediatr Cardiol       Date:  2014-04-23       Impact factor: 1.655

Review 3.  Immunological considerations-HLA matching and management of high immunological risk recipients.

Authors:  Olga Timofeeva; James Brown
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-07-29

Review 4.  Overview of lung transplantation.

Authors:  Marlyn S Woo
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

5.  Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation.

Authors:  Giuseppe Vassalli; Giuseppina Milano; Tiziano Moccetti
Journal:  J Transplant       Date:  2012-03-18

6.  Molecular-level HLA mismatch is associated with rejection and worsened graft survival in heart transplant recipients - a retrospective study.

Authors:  Emilio Osorio-Jaramillo; Geert W Haasnoot; Alexandra Kaider; Anne-Kristin Schaefer; Thomas Haberl; Johannes Goekler; Philipp Angleitner; Roxana Moayedifar; Andreas Zuckermann; Gottfried F Fischer; Guenther Laufer; Frans H J Claas; Arezu Z Aliabadi-Zuckermann
Journal:  Transpl Int       Date:  2020-06-23       Impact factor: 3.782

Review 7.  Winter is coming: the future of cryopreservation.

Authors:  Sanja Bojic; Alex Murray; Roman Bauer; João Pedro de Magalhães; Barry L Bentley; Ralf Spindler; Piotr Pawlik; José L Cordeiro
Journal:  BMC Biol       Date:  2021-03-24       Impact factor: 7.431

Review 8.  Cardiac allograft vasculopathy: current review and future research directions.

Authors:  Jordan S Pober; Sharon Chih; Jon Kobashigawa; Joren C Madsen; George Tellides
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.